CytoViva
Private Company
Funding information not available
Overview
CytoViva is a private technology company and the self-described worldwide leader in hyperspectral microscopy, providing integrated hardware and software solutions for nanoscale imaging. Its patented Enhanced Darkfield illumination, combined with hyperspectral imaging, allows for the label-free visualization and spectral analysis of samples ranging from nanomaterials to biological tissues. The company serves a diverse research market, including academia, government, and industry, with applications in nano-toxicology, drug delivery, pathology, and materials science. CytoViva operates on a product sales and customization model, configuring systems to meet specific client research needs.
Technology Platform
Patented Enhanced Darkfield (EDF) microscopy illuminator integrated with Hyperspectral Imaging (HSI) for label-free visualization and spectral characterization of nanoscale and microscale samples in biological and materials science applications.
Opportunities
Risk Factors
Competitive Landscape
CytoViva competes in the high-end microscopy market against giants like Zeiss, Leica, Nikon, and Olympus, which offer broad portfolios but lack an identical integrated EDF-HSI solution. It also faces competition from other hyperspectral imaging specialists and companies focusing on complementary label-free techniques like Raman microscopy. Its differentiation is its patented EDF optics optimized for nanoscale contrast.